The evolving role of bisphosphonates: cancer treatment-induced bone loss.
Mundy
Gregory R
GR
Department of Cellular and Structural Biology, Division of Endocrinology, University of Texas Health Science Center, San Antonio, Texas 78229-3900, USA. mundy@uthscsa.edu
D000970:Antineoplastic Agents / Q000009:adverse effects; D004164:Diphosphonates / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000628:therapy*; D010024:Osteoporosis / Q000188:drug therapy* / Q000209:etiology; D011878:Radiotherapy / Q000009:adverse effects; D013514:Surgical Procedures, Operative / Q000009:adverse effects
D000970:Antineoplastic Agents; D004164:Diphosphonates